About The ASCO Post
Rights and Permissions
In the Clinic
View By Issue
ASCO Breakthrough: A Global Summit for Oncology Innovators
ESMO 2019 Congress
NCCN 2019 Annual Congress: Hematologic Malignancies
2019 ASTRO Annual Meeting
IASLC 2019 World Conference on Lung Cancer
Biomarkers in Immunotherapy
IMPROVING NSCLC OUTCOMES
Methotrexate–Induced Kidney Injury
No results found for "Daniel F. Hayes, MD, FACP, FASCO"
Ensure words are spelled correctly.
Try rephrasing keywords or using synonyms.
Try less specific keywords.
Today In Oncology
Out-of-Pocket Costs for Oral Tyrosine Kinase Inhibitors and Survival in Advanced Lung Cancer
Evidence Supports Immunotherapy Plus Chemo for Early Triple-Negative Breast Ca
Exercise for Patients With Cancer to Minimize Treatment Cardiotoxicity
FDA Pipeline Designations for Acute GVHD, PTCL
Patient Preference for More vs Less Medical Care for Thyroid Cancer
Most Read Stories
RELAY Trial: Addition of Ramucirumab to Erlotinib in Previously Untreated,
-Mutated Advanced NSCLC
ASCO Breakthrough: Breast Cancer Gene Expression Signature May Help Predict Recurrence Postradiotherapy
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): 2016 Guidelines
Nivolumab vs Chemotherapy in Previously Treated Advanced Esophageal Squamous Cell Carcinoma
Management of HER2-Positive Breast Cancer: Business as Usual?
© 2019 HSP News Service, L.L.C.